Trident Lifeline Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003715,
    "name": "Trident Lifeline",
    "stock_name": "Trident Lifeline",
    "full_name": "Trident Lifeline Ltd",
    "name_url": "stocks-analysis/trident-lifeline",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "290.25",
    "chg": -12.75,
    "chgp": "-4.21%",
    "dir": -1,
    "prev_price": "303.00",
    "mcapval": "362.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543616,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0MKA01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": 6000,
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/trident-lifeline-1003715-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/trident-lifeline-upgraded-to-buy-by-marketsmojo-on-strong-financial-and-quality-metrics-3741253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TridentLifeline_mojoScore_3741253.png",
        "date": "2025-12-02 10:09:20",
        "description": "Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective."
      },
      {
        "title": "Trident Lifeline Reports Strong Financial Performance Amid Mixed Stock Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/trident-lifelines-financial-trend-improves-from-flat-to-very-positive-with-record-sales-3697624",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TridentLifeline_fintrenddot_3697624.png",
        "date": "2025-11-13 12:02:48",
        "description": "Trident Lifeline, a microcap in the Pharmaceuticals & Biotechnology sector, reported strong financial results for the quarter ending September 2025, with record net sales and profit figures. Despite recent stock challenges, the company has shown significant long-term growth, outperforming the Sensex over a three-year period."
      },
      {
        "title": "How has been the historical performance of Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-trident-lifeline-3695730",
        "imagepath": "",
        "date": "2025-11-13 00:37:15",
        "description": "Answer:\nThe historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years.\n\nBreakdown:\nTrident Lifeline's net sales have increased from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25. Operating profit (PBDIT) has improved markedly, from 3.31 Cr in Mar'22 to 23.08 Cr in Mar'25, although the operating profit margin has slightly decreased from 12.45% to 17.08%. Profit before tax has risen from 2.98 Cr to 13.61 Cr, leading to a profit after tax increase from 3.95 Cr to 10.49 Cr. The consolidated net profit has also shown growth, moving from 3.95 Cr in Mar'22 to 11.75 Cr in Mar'25. On the balanc..."
      },
      {
        "title": "How has been the historical performance of Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-trident-lifeline-3694967",
        "imagepath": "",
        "date": "2025-11-13 00:02:11",
        "description": "Answer:\nThe historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years.\n\nBreakdown:\nTrident Lifeline's net sales have increased dramatically from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure also grew, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) saw a substantial increase, reaching 23.08 Cr in Mar'25, up from just 3.31 Cr in Mar'22. Profit before tax rose from 2.98 Cr in Mar'22 to 13.61 Cr in Mar'25, while profit after tax increased from 3.95 Cr to 10.49 Cr in the same timeframe. The earnings per share (EPS) improved significantly from 4.94 in Mar'22 to 10.22 in Mar'25. On the balance shee..."
      },
      {
        "title": "Why is Trident Lifeline falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-trident-lifeline-fallingrising-3691413",
        "imagepath": "",
        "date": "2025-11-12 00:04:00",
        "description": "As of 11-Nov, Trident Lifeline Ltd's stock price is rising, currently at Rs 318.00, reflecting an increase of Rs 17.25 or 5.74%. The stock has shown strong performance today, outperforming its sector by 5.87% and is close to its 52-week high, just 2.19% away from Rs 324.95. Despite a recent trend reversal after two days of consecutive declines, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 58.70% and operating profit at 55.07%. Institutional investors have also increased their stake by 0.52% in the last quarter, indicating growing confidence in the company's fundamentals.\n\nIn the broader market context, Trident Lifeline's short-term return over the past week is +6.00%, significantly outperforming the Sensex, which has only gained +0.49% during the ..."
      },
      {
        "title": "When is the next results date for Trident Lifeline?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-trident-lifeline-3677513",
        "imagepath": "",
        "date": "2025-11-06 23:16:33",
        "description": "The next results date for Trident Lifeline is scheduled for 11 November 2025...."
      }
    ],
    "total": 118,
    "sid": "1003715",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/trident-lifeline-1003715"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "02-Feb-2026",
      "details": "We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421) a subsidiary company has allotted Bonus shares to their existing members. Pursuant to the above bonus allotment of 934160 new shares to Trident Lifeline Limited the shareholding of Trident Lifeline Limited in Trident Mediquip Limited remains same at 60.04%.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "20-Jan-2026",
      "details": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Earnings Presentation for the quarter ended 31st December 2025 (Q3FY26).",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Jan-2026",
      "details": "In accordance with Regulation 47 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations we hereby enclose copies of newspaper advertisement published on January 19 2026 regarding extract of the Un-Audited Standalone and Consolidated Financial Statements for the quarter ended 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Trident Lifeline Sees Revision in Market Evaluation Amid Strong Financial Trends

2025-12-02 10:09:20

Trident Lifeline, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation metrics. This shift reflects a reassessment of the company’s financial health, valuation, technical outlook, and overall quality, signalling renewed investor interest and a changing market perspective.

Trident Lifeline Reports Strong Financial Performance Amid Mixed Stock Market Trends

2025-11-13 12:02:48

Trident Lifeline, a microcap in the Pharmaceuticals & Biotechnology sector, reported strong financial results for the quarter ending September 2025, with record net sales and profit figures. Despite recent stock challenges, the company has shown significant long-term growth, outperforming the Sensex over a three-year period.

How has been the historical performance of Trident Lifeline?

2025-11-13 00:37:15

Answer: The historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years. Breakdown: Trident Lifeline's net sales have increased from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income has followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure, excluding depreciation, has also grown, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25. Operating profit (PBDIT) has improved markedly, from 3.31 Cr in Mar'22 to 23.08 Cr in Mar'25, although the operating profit margin has slightly decreased from 12.45% to 17.08%. Profit before tax has risen from 2.98 Cr to 13.61 Cr, leading to a profit after tax increase from 3.95 Cr to 10.49 Cr. The consolidated net profit has also shown growth, moving from 3.95 Cr in Mar'22 to 11.75 Cr in Mar'25. On the balanc...

How has been the historical performance of Trident Lifeline?

2025-11-13 00:02:11

Answer: The historical performance of Trident Lifeline shows significant growth in various financial metrics over the past four years. Breakdown: Trident Lifeline's net sales have increased dramatically from 21.77 Cr in Mar'22 to 86.96 Cr in Mar'25, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 21.77 Cr to 86.96 Cr during the same period. The company's total expenditure also grew, from 19.06 Cr in Mar'22 to 72.11 Cr in Mar'25, driven by higher raw material costs and employee expenses. Operating profit (PBDIT) saw a substantial increase, reaching 23.08 Cr in Mar'25, up from just 3.31 Cr in Mar'22. Profit before tax rose from 2.98 Cr in Mar'22 to 13.61 Cr in Mar'25, while profit after tax increased from 3.95 Cr to 10.49 Cr in the same timeframe. The earnings per share (EPS) improved significantly from 4.94 in Mar'22 to 10.22 in Mar'25. On the balance shee...

Why is Trident Lifeline falling/rising?

2025-11-12 00:04:00

As of 11-Nov, Trident Lifeline Ltd's stock price is rising, currently at Rs 318.00, reflecting an increase of Rs 17.25 or 5.74%. The stock has shown strong performance today, outperforming its sector by 5.87% and is close to its 52-week high, just 2.19% away from Rs 324.95. Despite a recent trend reversal after two days of consecutive declines, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 58.70% and operating profit at 55.07%. Institutional investors have also increased their stake by 0.52% in the last quarter, indicating growing confidence in the company's fundamentals. In the broader market context, Trident Lifeline's short-term return over the past week is +6.00%, significantly outperforming the Sensex, which has only gained +0.49% during the ...

When is the next results date for Trident Lifeline?

2025-11-06 23:16:33

The next results date for Trident Lifeline is scheduled for 11 November 2025....

View All News